Gastroenterology
Volume 136, Issue 1 , Pages 288-298 , January 2009

Polymeric Binders Suppress Gliadin-Induced Toxicity in the Intestinal Epithelium

  • Maud Pinier

      Affiliations

    • Faculty of Pharmacy, University of Montreal, Montreal, Canada
    • ,
  • Elena F. Verdu

      Affiliations

    • Intestinal Disease Research Programme, Faculty of Health Sciences, McMaster University, Hamilton, Canada
    • ,
  • Mohamad Nasser–Eddine

      Affiliations

    • Faculty of Pharmacy, University of Montreal, Montreal, Canada
    • ,
  • Chella S. David

      Affiliations

    • Department of Immunology, Mayo Clinic, Rochester, New York
    • ,
  • Anne Vézina

      Affiliations

    • CIHR Team in Digestive Epithelium, Department of Anatomy and Cellular Biology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada
    • ,
  • Nathalie Rivard

      Affiliations

    • CIHR Team in Digestive Epithelium, Department of Anatomy and Cellular Biology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada
    • ,
  • Jean–Christophe Leroux

      Affiliations

    • Faculty of Pharmacy, University of Montreal, Montreal, Canada
    • Corresponding Author InformationAddress requests for reprints to: Jean–Christophe Leroux, Faculty of Pharmacy, University of Montreal, Montreal, QC, Canada. fax: (514) 343-6455

Received 22 February 2008 ,Accepted 11 September 2008.

References 

  1. Mulder CJ, Cellier C. Coeliac disease: changing views. Best Pract Res Clin Gastroenterol. 2005;19:313–321
  2. Maki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med. 2003;348:2517–2524
  3. Wahnschaffe U, Schulzke JD, Zeitz M, et al. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2007;5:844–850
  4. Shan L, Molberg O, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue. Science. 2002;297:2275–2279
  5. Anderson RP, Degano P, Godkin AJ, et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med. 2000;6:337–342
  6. Maiuri L, Ciacci C, Ricciardelli I, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet. 2003;362:30–37
  7. Benahmed M, Meresse B, Arnulf B, et al. Inhibition of TGF-β signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology. 2007;132:994–1008
  8. Sollid LM, Khosla C. Future therapeutic options for celiac disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2:140–147
  9. De Angelis M, Rizzello CG, Fasano A, et al. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue. Biochim Biophys Acta. 2006;1762:80–93
  10. Wang W, Uzzau S, Goldblum SE, et al. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci. 2000;113:4435–4440
  11. Watts RE, Siegel M, Khosla C. Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles. J Med Chem. 2006;49:7493–7501
  12. Xia J, Siegel M, Bergseng E, et al. Inhibition of HLA-DQ2-mediated antigen presentation by analogues of a high affinity 33-residue peptide from α2-gliadin. J Am Chem Soc. 2006;128:1859–1867
  13. Salvati VM, Mazzarella G, Gianfrani C, et al. Recombinant human interleukin 10 suppresses gliadin dependent T-cell activation in ex vivo cultured coeliac intestinal mucosa. Gut. 2005;54:46–53
  14. Di Sabatino A, Ciccocioppo R, Cupelli F, et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut. 2006;55:469–477
  15. Hischenhuber C, Crevel R, Jarry B, et al. Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Aliment Pharmacol Ther. 2006;23:559–575
  16. Di Cagno R, De Angelis M, Auricchio S, et al. Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients. Appl Environ Microbiol. 2004;70:1088–1096
  17. Gianfrani C, Siciliano RA, Facchiano AM, et al. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology. 2007;133:780–789
  18. Dhal PK, Holmes-Farley RS, Huval CC, et al. Polymers as drugs. Adv Polym Sci. 2006;192:9–58
  19. Vachon PH, Beaulieu JF. Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology. 1992;103:414–423
  20. Perreault N, Beaulieu JF. Primary cultures of fully differentiated and pure human intestinal epithelial cells. Exp Cell Res. 1998;245:34–42
  21. Laprise P, Viel A, Rivard N. Human homolog of disc-large is required for adherens junction assembly and differentiation of human intestinal epithelial cells. J Biol Chem. 2004;279:10157–10166
  22. Garneau H, Alvarez L, Paquin MC, et al. Nuclear expression of E2F4 induces cell death via multiple pathways in normal human intestinal epithelial crypt cells but not in colon cancer cells. Am J Physiol Gastrointest Liver Physiol. 2007;293:G758–G772
  23. Cheng S, Smart M, Hanson J, et al. Characterization of HLA DR2 and DQ8 transgenic mouse with a new engineered mouse class II deletion, which lacks all endogenous class II genes. J Autoimmun. 2003;21:195–199
  24. Verdu EF, Huang X, Natividad J, et al. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am J Physiol Gastrointest Liver Physiol. 2008;294:G217–G225
  25. Kiliaan AJ, Saunders PR, Bijlsma PB, et al. Stress stimulates transepithelial macromolecular uptake in rat jejunum. Am J Physiol. 1998;275:G1037–G1044
  26. Biagi F, Luinetti O, Campanella J, et al. Intraepithelial lymphocytes in the villous tip: do they indicate potential coeliac disease?. J Clin Pathol. 2004;57:835–839
  27. Liang L, Pinier M, Leroux JC, et al. interaction of a a-gliadin with poly(HEMA-co-SS): structural characterization and biological implication. Biopolymers. 2008;In press
  28. Dolfini E, Elli L, Roncoroni L, et al. Damaging effects of gliadin on three-dimensional cell culture model. World J Gastroenterol. 2005;11:5973–5977
  29. Dolfini E, Roncoroni L, Elli L, et al. Cytoskeleton reorganization and ultrastructural damage induced by gliadin in a three-dimensional in vitro model. World J Gastroenterol. 2005;11:7597–7601
  30. Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol. 2002;169:5595–5600
  31. Insull W, Marquis NR, Tsianco MC. Comparison of the efficacy of Questran Light, a new formulation of cholestyramine powder, to regular Questran in maintaining lowered plasma cholesterol levels. Am J Cardiol. 1991;67:501–505
  32. Thomas KE, Sapone A, Fasano A, et al. Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in celiac disease. J Immunol. 2006;176:2512–2521
  33. Clemente MG, De Virgiliis S, Kang JS, et al. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut. 2003;52:218–223
  34. Khosla C, Gray GM, Sollid LM. Putative efficacy and dosage of prolyl endopeptidase for digesting and detoxifying gliadin peptides. Gastroenterology. 2005;129:1362–1363
  35. Gass J, Vora H, Bethune MT, et al. Effect of barley endoprotease EP-B2 on gluten digestion in the intact rat. J Pharmacol Exp Ther. 2006;318:1178–1186
  36. Siegel M, Bethune MT, Gass J, et al. Rational design of combination enzyme therapy for celiac sprue. Chem Biol. 2006;13:649–658
  37. Pyle GG, Paaso B, Anderson BE, et al. Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue. Clin Gastroenterol Hepatol. 2005;3:687–694
  38. Cornell HJ, Macrae FA, Melny J, et al. Enzyme therapy for management of coeliac disease. Scand J Gastroenterol. 2005;40:1304–1312
  39. Catassi C, Fabiani E, Iacono G, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr. 2007;85:160–166
  40. Esposito C, Caputo I, Auricchio S, et al. Tissue transglutaminase and celiac disease. Prog Exp Tumor Res. 2005;38:158–173

 The authors disclose the following: Supported by the Canadian Celiac Association, Fonds Québécois de la Recherche sur la Nature et les Technologies, Canadian Institutes of Health Research (to N.R.), National Institutes of Health DK 071003 (to C.S.D.), CAG/CIHR New Investigator Establishment Award (to E.F.V.), and the Canada Research Chair program.

PII: S0016-5085(08)01681-8

doi: 10.1053/j.gastro.2008.09.016

Gastroenterology
Volume 136, Issue 1 , Pages 288-298 , January 2009

Article Tools

* Image Usage & Resolution